未登录

F

Fabio Bottari

European Institute of Oncology IRCCS

H指数:17

被引数:868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical performance of the BD Onclarity™ HPV extended genotyping assay for anal cancer screening: a prospective pilot study

BD Onclarity™ HPV扩展分型检测在肛门癌筛查中的临床性能：一项前瞻性试点研究

Journal of Clinical Virology

IF3.4

2025-07-280

PRE

Clinical accuracy of OncoPredict HPV Quantitative Typing (QT) assay on self-samples

JOURNAL OF CLINICAL VIROLOGY

IF3.4

2024-12-012

OAAI

Clinical Performance of OncoPredict HPV Screening Assay on Self-Collected Vaginal and Urine Specimens Within the VALHUDES Framework

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2024-11-260

OAAI

Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples

BD Onclarity HPV检测在FLOQSwabs阴道自身样本上的性能

MICROBIOLOGY SPECTRUM

IF3.8

2024-03-0510

OAAI

Human Papillomavirus Genotype Richness and the Biodiversity of Squamous and Glandular Cervical Dysplasias: A Cross-Sectional Study

IF3.3

2023-10-110

OAAI

The Editorial of the Special Issue Diagnosis of Lower Genital Tract Disease

IF3.3

2023-07-280

OAAI

Tips and Tricks for Early Diagnosis of Cervico-Vaginal Involvement from Extramammary Paget's Disease of the Vulva: A Referral Center Experience

IF3.3

2023-01-271

OAAI

Deep learning based identification of bone scintigraphies containing metastatic bone disease foci

IF3.5

2023-01-257

OAAI

Which Risk Factors and Colposcopic Patterns Are Predictive for High-Grade VAIN? A Retrospective Analysis

IF3.3

2023-01-044

OAAI

Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study

IF3.3

2022-12-0713

OAAI

HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions

IF3.3

2022-09-295

OAAI

New Analytical Approach for the Alignment of Different HE4 Automated Immunometric Systems: An Italian Multicentric Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-04-028

OAAI

Anyplex II HPV test in detection and follow-up after surgical treatment of CIN2+lesions

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2021-02-151

PREAI

Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia A Systematic Review

OBSTETRICS AND GYNECOLOGY

IF4.7

2019-09-0119

OAAI

Profile of the BD HPV OnclarityTM assay

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2019-06-036

PREAI

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2019-04-3026

OAAI

Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+in two time periods

INFECTIOUS DISEASES

IF2.3

2018-02-206

PREAI

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

JOURNAL OF CLINICAL MICROBIOLOGY

IF5.4

2016-09-0130

OAAI

HPV-Testing in Follow-up of Patients Treated for CIN2+Lesions

JOURNAL OF CANCER

IF3.2

2016-01-0132

OAAI

Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions

JOURNAL OF CLINICAL MICROBIOLOGY

IF5.4

2015-07-0122

OAAI